Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2012 - 2020)

Cumberland Pharmaceuticals has disclosed Deferred Taxes across 9 years of filings, most recently posting $21802.0 for Q4 2020.

• Deferred Taxes for Q4 2020 came in at $21802.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2020 was $21802.0 (down 66.67% YoY), and the FY2020 annual result was $21802.0, down 66.67% from the prior year.
• Deferred Taxes came in at $21802.0 for Q4 2020 at Cumberland Pharmaceuticals, roughly flat from $21803.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $3.5 million in Q2 2017 to a low of -$87210.0 in Q4 2017.
• The 5-year median for Deferred Taxes is $81886.0 (2018), against an average of $454129.9.
• Peak annual rise in Deferred Taxes reached 1294.48% in 2016, while the deepest fall reached 109.66% in 2016.
• Cumberland Pharmaceuticals' Deferred Taxes stood at -$43109.0 in 2016, then slumped by 102.3% to -$87210.0 in 2017, then jumped by 193.9% to $81886.0 in 2018, then tumbled by 73.37% to $21803.0 in 2019, then fell by 0.0% to $21802.0 in 2020.
• The last three Deferred Taxes figures came in at $21802.0 (Q4 2020), $21803.0 (Q4 2019), and $43605.0 (Q1 2019), per Business Quant data.